Ben Schmand
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Ben Schmand has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
Willem A. van Gool
Department of Neurology, Academic Medical Center, Amsterdam, The Netherlands
3 shared publicationsPiet Eikelenboom
Department of Neurology, Academic Medical Centre, Amsterdam, The Netherlands
2 shared publicationsAnne Rienstra
Department of Psychology, University of Amsterdam, Amsterdam, The Netherlands
1 shared publicationCharles B. Majoie
Department of Radiology, Academic Medical Center, Amsterdam, The Netherlands
1 shared publication- Diederik van de Beek
Amsterdam UMC
1 shared publication Ed de Bruin
Department of Psychology, University of Amsterdam, The Netherlands
1 shared publication
Latest Publications
- 31 March 2014
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 40 (2) , 409-418
Responsiveness of Magnetic Resonance Imaging and Neuropsychological Assessment in Memory Clinic Patients
Background: Scales of global cognition and behavior, often used as endpoints for intervention trials in Alzheimer’s disease (AD) and mild cognitive impairment (MCI), are insufficiently responsive (i.e., relatively insensitive to change). Large patien
- 31 March 2014
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 40 (2) , 409-418
Responsiveness of Magnetic Resonance Imaging and Neuropsychological Assessment in Memory Clinic Patients
Background: Scales of global cognition and behavior, often used as endpoints for intervention trials in Alzheimer’s disease (AD) and mild cognitive impairment (MCI), are insufficiently responsive (i.e., relatively insensitive to change). Large patien
- 30 March 2012
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 29 (3) , 641-648
Value of Diagnostic tests to Predict Conversion to Alzheimer's Disease in Young and Old Patients with Amnestic Mild Cognitive Impairment
Using the database of the Alzheimer's Disease Neuroimaging Initiative, we examined the value of neuropsychological assessment, structural magnetic resonance imaging (MRI), cerebrospinal fluid (CSF) biomarkers, and FDG-PET scanning with respect to pre
- 30 March 2012
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 29 (3) , 641-648
Value of Diagnostic tests to Predict Conversion to Alzheimer's Disease in Young and Old Patients with Amnestic Mild Cognitive Impairment
Using the database of the Alzheimer's Disease Neuroimaging Initiative, we examined the value of neuropsychological assessment, structural magnetic resonance imaging (MRI), cerebrospinal fluid (CSF) biomarkers, and FDG-PET scanning with respect to pre
- 24 August 2011
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 59 (9) , 1705-1710
Value of Neuropsychological Tests, Neuroimaging, and Biomarkers for Diagnosing Alzheimer's Disease in Younger and Older Age Cohorts
OBJECTIVES: To examine the influence of age on the value of four techniques for diagnosing Alzheimer's disease (AD). DESIGN: Observational cohort study. SETTING: Alzheimer's Disease Neuroimaging Initiative. PARTICIPANTS: Individuals with mild cognitive impairment (MCI; n=179), individuals with AD (n=91), and normal controls (n=105). MEASUREMENTS: Neuropsychological tests, structural magnetic resonance imaging (MRI), amyloid‐beta and tau in cerebrospinal fluid (CSF), and [18F]fluorodeoxyglucose positron emission tomography (FDG‐PET) for the diagnosis of MCI or AD. MCI was defined according to subjective memory complaints corroborated by an informant and an abnormal score on the delayed paragraph recall subtest of the Wechsler Memory Scale–Revised, a Mini‐Mental State Examination score greater than 23, and a Clinical Dementia Rating score of 0.5. Participants with AD satisfied National Institute of Neurological and Communicative Diseases and Stroke/Alzheimer's Disease and Related Disorders Association criteria of probable AD. RESULTS: Neuropsychological tests and MRI were the most informative techniques, with 84% and 82% correct classifications, respectively, and areas under the receiver operating characteristic curve (AUCs) of 0.93 (90% confidence interval (CI)=0.91–0.95) and 0.88 (90% CI=0.85–0.91). FDG‐PET and CSF assessments had 76% and 73% correct classifications, respectively, (AUC=0.77, 90% CI=0.71–0.83; AUC=0.77, 90% CI=0.73–0.82). These figures increased slightly when the techniques were combined. All analyses were repeated for the younger (CONCLUSIONS: Structural MRI and neuropsychological assessment are diagnostic methods of first choice if AD is suspected. CSF and FDG‐PET add little to these diagnostic techniques, especially in older adults.
- 24 August 2011
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 59 (9) , 1705-1710
Value of Neuropsychological Tests, Neuroimaging, and Biomarkers for Diagnosing Alzheimer's Disease in Younger and Older Age Cohorts
OBJECTIVES: To examine the influence of age on the value of four techniques for diagnosing Alzheimer's disease (AD). DESIGN: Observational cohort study. SETTING: Alzheimer's Disease Neuroimaging Initiative. PARTICIPANTS: Individuals with mild cognitive impairment (MCI; n=179), individuals with AD (n=91), and normal controls (n=105). MEASUREMENTS: Neuropsychological tests, structural magnetic resonance imaging (MRI), amyloid‐beta and tau in cerebrospinal fluid (CSF), and [18F]fluorodeoxyglucose positron emission tomography (FDG‐PET) for the diagnosis of MCI or AD. MCI was defined according to subjective memory complaints corroborated by an informant and an abnormal score on the delayed paragraph recall subtest of the Wechsler Memory Scale–Revised, a Mini‐Mental State Examination score greater than 23, and a Clinical Dementia Rating score of 0.5. Participants with AD satisfied National Institute of Neurological and Communicative Diseases and Stroke/Alzheimer's Disease and Related Disorders Association criteria of probable AD. RESULTS: Neuropsychological tests and MRI were the most informative techniques, with 84% and 82% correct classifications, respectively, and areas under the receiver operating characteristic curve (AUCs) of 0.93 (90% confidence interval (CI)=0.91–0.95) and 0.88 (90% CI=0.85–0.91). FDG‐PET and CSF assessments had 76% and 73% correct classifications, respectively, (AUC=0.77, 90% CI=0.71–0.83; AUC=0.77, 90% CI=0.73–0.82). These figures increased slightly when the techniques were combined. All analyses were repeated for the younger (CONCLUSIONS: Structural MRI and neuropsychological assessment are diagnostic methods of first choice if AD is suspected. CSF and FDG‐PET add little to these diagnostic techniques, especially in older adults.
- 31 October 2010
- Published by Elsevier in Journal of Infection
- Vol. 61 (4) , 330-334
Cognitive functioning and quality of life nine years after bacterial meningitis
- 31 October 2010
- Published by Elsevier in Journal of Infection
- Vol. 61 (4) , 330-334
Cognitive functioning and quality of life nine years after bacterial meningitis